FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/083790 [Registered on: 01/04/2025] Trial Registered Prospectively
Last Modified On: 27/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Randomized Control Study of bladder catheterization vs non-catheterization in patients post semirigid Ureterorenoscopic Lithotripsy (URSL) with DJ stenting. 
Scientific Title of Study   Randomized Control Study of patients post semirigid Ureterorenoscopic Lithotripsy (URSL) with DJ stenting undergoing bladder catheterization vs non-catheterization.  
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Harsh Dinesh Bhalsod 
Designation  Registrar 
Affiliation  Kasturba Medical College 
Address  Department of Urology and Renal Transplant, Kasturba Medical College, Tiger circle Road, Madhav Nagar, Eshwar Nagar, Manipal

Udupi
KARNATAKA
576104
India 
Phone  9164118514  
Fax    
Email  bhalsodharsh94@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sunil Pillai 
Designation  Professor and HOD 
Affiliation  Kasturba Medical College 
Address  Department of Urology and Renal Transplant, Kasturba Medical College, Tiger circle Road, Madhav Nagar, Eshwar Nagar, Manipal

Udupi
KARNATAKA
576104
India 
Phone  9731855209  
Fax    
Email  sunil.pillai@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Harsh Dinesh Bhalsod 
Designation  Registrar 
Affiliation  Kasturba Medical College 
Address  Department of Urology and Renal Transplant, Kasturba Medical College, Tiger circle Road, Madhav Nagar, Eshwar Nagar, Manipal

Udupi
KARNATAKA
576104
India 
Phone  9164118514  
Fax    
Email  bhalsodharsh94@gmail.com  
 
Source of Monetary or Material Support  
Kasturba Medical College, Madhavnagar, Manipal, Udupi-576104, Karnataka 
 
Primary Sponsor  
Name  Kasturba Medical College and Hospital Manipal 
Address  Department of Urology and Renal Transplant, Kasturba Medical College, Tiger Circle Road, Madhav Nagar, Manipal, Karnataka 576104 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Harsh Dinesh Bhalsod  Kasturba Hospital, Manipal  Department of Urology and Renal Transplant, Kasturba Hospital, Manipal
Udupi
KARNATAKA 
9164118514

bhalsodharsh94@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N201||Calculus of ureter,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Bladder catheterization  Foleys catheter in control group patient Foleys 14 Fr in females and males 
Comparator Agent  Non-catheterization  Patients will be randomised into groups after undergoing URSL and DJ stenting. Both the groups will be looked for post operative pain, IPSS, USSQ and post operative complications. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  URSL performed under general/spinal anesthesia with insertion of Double J ureteral stent
Foleys catheter in the control group patient - Foleys no 14 in females and males 
 
ExclusionCriteria 
Details  Age less than 18 years
Bilateral URSL
URSL without stenting
Previous history of URSL
Pre existing urethral/Bladder outlet pathology 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
International Prostate Symptom Score (IPSS).
Post-operative pain, Visual Analogue Scale (VAS)
Ureteric Stent Symptomatic Score (USSQ)  
Pre-operatively, Post operative POD 0 (6hrs), POD 1 
 
Secondary Outcome  
Outcome  TimePoints 
Post operative fever more than 100 degree
USG for Hydronephrosis, Post Void Residue (PVR) seen before discharge
Emergency visits, readmission after discharge
Any history of lithuria  
Pre operatively, Post operative day POD 0 at 6 hr, POD1.  
 
Target Sample Size   Total Sample Size="141"
Sample Size from India="141" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patients presenting to Kasturba Hospital Manipal, Department of urology and Renal Transplant with ureteric calculi will be recruited from the OPD for the study. 
Informed consent will be taken.
Lithotripsy will be done with pneumatic lithotripter or Laser as per surgeons’ preference. 
Clearance of stone fragments will be confirmed on ureteroscopy and fluoroscopy. 
Then, Patients will be randomized into 2 groups by using simple computer-generated randomization 
Group 1 patients (control group) will undergo Bladder catheterization and Group 2 patients (study group) will not be subjected to a catheter.
All patients will be evaluated for post operative pain, fever, IPSS and USSQ- pre operatively, POD0- at 6 hr (from the time the patient fully awakens from general anesthesia or regains motor control after spinal anesthesia) and on POD1. 
All patients will be prescribed oral antibiotics for one week and oral analgesics for 7 days post discharge.
Ultrasonography of the patients will be done just before the discharge to measure PVR and hydronephrosis.  
 
Close